# Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck Cancer

> **NCT07704372** · PHASE2 · NOT_YET_RECRUITING · sponsor: **West China Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Radiation-induced Dermatitis

## Interventions

- **DRUG:** A topical superoxide dismutase skin spray
- **OTHER:** Placebo Spray

## Key facts

- **NCT ID:** NCT07704372
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07704372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07704372, "Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07704372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*